vimarsana.com

Latest Breaking News On - Cyclerion therapeutics daily - Page 1 : vimarsana.com

Contrasting Cyclerion Therapeutics (NASDAQ:CYCN) & Nuvo Pharmaceuticals (OTCMKTS:MRVFF)

Contrasting Cyclerion Therapeutics (NASDAQ:CYCN) & Nuvo Pharmaceuticals (OTCMKTS:MRVFF)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Short Interest in Cyclerion Therapeutics, Inc (NASDAQ:CYCN) Drops By 14 5%

Cyclerion Therapeutics, Inc. (NASDAQ:CYCN – Get Free Report) was the recipient of a significant decline in short interest during the month of September. As of September 30th, there was short interest totalling 15,900 shares, a decline of 14.5% from the September 15th total of 18,600 shares. Based on an average daily volume of 8,600 shares, […]

Cyclerion Therapeutics, Inc (NASDAQ:CYCN) Short Interest Up 20 0% in July

Cyclerion Therapeutics, Inc. (NASDAQ:CYCN – Get Free Report) saw a large growth in short interest in the month of July. As of July 15th, there was short interest totalling 33,600 shares, a growth of 20.0% from the June 30th total of 28,000 shares. Approximately 1.6% of the shares of the company are short sold. Based […]

Cyclerion Therapeutics (NASDAQ:CYCN) Stock Price Up 0 7%

Cyclerion Therapeutics, Inc. (NASDAQ:CYCN – Free Report)’s stock price rose 0.7% during trading on Tuesday . The stock traded as high as $4.17 and last traded at $4.15. Approximately 6,061 shares were traded during trading, a decline of 60% from the average daily volume of 15,031 shares. The stock had previously closed at $4.12. Cyclerion […]

Cyclerion Therapeutics, Inc (NASDAQ:CYCN) Short Interest Update

Cyclerion Therapeutics, Inc. (NASDAQ:CYCN – Get Rating) was the target of a large growth in short interest in May. As of May 31st, there was short interest totalling 36,200 shares, a growth of 168.1% from the May 15th total of 13,500 shares. Currently, 1.9% of the company’s stock are sold short. Based on an average […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.